Aristo Pharma Nordic ApS
CVR 32328768 · Private limited company (ApS) · Active · Low risk
Aristo Pharma Nordic ApS is a Private limited company (ApS), founded on , based in Skovlunde. The company is registered in the industry engroshandel med læge- og hospitalsartikler. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 15 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 185k and a net result of DKK 22k. CEO: John Hudson Kriwet.
Bankruptcy risk for Aristo Pharma Nordic ApS
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 32328768
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (15 years)
- Address
- Tonsbakken 16, 2.
2740 Skovlunde - Municipality
- Ballerup
- Industry
- Engroshandel med læge- og hospitalsartikler (464620)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 107k
- Employees
- 8 (2018)
- Auditor
- Baker Tilly Denmark
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 3 of 15 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 6.2% |
| Current ratio | 4,498% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 14 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 63 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | DKK 453k | DKK 529k | DKK 543k |
| Gross profit | DKK 315k | DKK 363k | DKK 327k |
| Net profit | DKK 22k | DKK 25k | DKK 26k |
| Equity | DKK 185k | DKK 163k | DKK 138k |
| Total assets | DKK 3.0m | DKK 2.5m | DKK 2.0m |
| Cash | DKK 18k | DKK 9,667 | – |
| Short-term debt | DKK 66k | DKK 70k | – |
| Avg. employees | 3 | 3 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Baker Tilly Denmark.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 111 | ||
| 1 Jan 2024 – 31 Dec 2024 | 161 | ||
| 1 Jan 2023 – 31 Dec 2023 | 100 | ||
| 1 Jan 2022 – 31 Dec 2022 | 117 | ||
| 1 Jan 2021 – 31 Dec 2021 | 187 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 194 | Late | |
| 1 Jan 2019 – 31 Dec 2019 | 247 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 148 | ||
| 1 Jan 2017 – 31 Dec 2017 | 150 | ||
| 1 Jan 2016 – 31 Dec 2016 | 151 | ||
| 1 Jan 2015 – 31 Dec 2015 | 155 | ||
| 1 Jan 2014 – 31 Dec 2014 | 147 | ||
| 1 Oct 2012 – 31 Dec 2013 | 125 | ||
| 1 Oct 2011 – 30 Sep 2012 | 155 | ||
| 8 Feb 2011 – 30 Sep 2011 | 139 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | John Hudson Kriwet | Current | |
| CEO | Peter Lassen | ||
| CEO | John Morell Frellsen | ||
| CEO | Lena Storm Christensen | ||
| CEO | János Váczi | ||
| CEO | Hasnain Nasir Butt | ||
| CEO | Sascha Rauschke | ||
| CEO | Kenneth Pedersen | ||
| CEO | Sascha Rauschke | ||
| Board | John Hudson Kriwet | Current | |
| Board | Robert Maciej Szymanski | Current | |
| Board | Jannes Paul Beeskow | Current | |
| Board | János Váczi | ||
| Board | Joseph Todisco | ||
| Board | Peter Prock | ||
| Board | János Váczi | ||
| Board | Chirag K Patel | ||
| Board | Chintu Patel | ||
| Board | János Váczi | ||
| Board | Hasnain Nasir Butt | ||
| Board | Sascha Rauschke | ||
| Board | Anton Alwin Karremann | ||
| Board | Christian Jaaks | ||
| Board | Christian Jaaks | ||
| Board | Kenneth Pedersen | ||
| Owner (100%) | Aristo Pharma GmbH | Current | |
| Owner (100%) | Amneal Pharmaceuticals Holding GmbH | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | EY Danmark A/S | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | AIDER Godkendt Revisionsaktieselskab | ||
| Founder | CHR. OLESEN PHARMACEUTICALS A/S | Current |
The CEOs' other companies
Peter Lassen – 3 other companies
- 1A FARMA A/S Fusioneret
- J.O. SPRECKELSEN ApS Active
- MATRIX PHARMACEUTICALS ApS Active
John Morell Frellsen – 11 other companies
- Bonorum Partners M&A A/S Active
- KJ KLIMATEKNIK A/S Active
- MORELLCO HOLDING ApS Active
- MORELLCO PHARMA DENMARK ApS Fusioneret
- Morellco Pharma A/S Opløst
- Negotium Partners ApS Active
- OMPAKNINGSSELSKABET AF 1. NOVEMBER 2005 A/S Opløst
- ORIFARM A/S Active
- ORIFARM GROUP A/S Active
- ORIFARM SUPPLY A/S Active
- SKINCODE DANMARK ApS Opløst
Lena Storm Christensen – 3 other companies
- AddStorm ApS Active
- AddStorm Holding ApS Active
- SWEDISH ORPHAN BIOVITRUM A/S Active
Hasnain Nasir Butt – 1 other companies, of which 1 bankrupt
- Mashal Healthcare A/S Bankrupt 13 Nov 2024
Address history (5 moves)
| Tonsbakken 16, 2., 2740 Skovlunde | |
| Tonsbakken 16, 2., 2740 Skovlunde | |
| Kanalholmen 14C, 1. th, 2650 Hvidovre | |
| Kanalholmen 14, 2650 Hvidovre | |
| Kanalholmen 8, 2650 Hvidovre | |
| Jægersborg Alle 164, 2820 Gentofte |
Former names
| Aristo Pharma Nordic ApS | – now |
| AMNEAL NORDIC ApS | – |
| COPHARMA ApS | – |
Employees per year
Other companies at the same address
- DANSKIB X ApS Bankrupt
- Mashal Healthcare A/S Bankrupt
- Mashal Holding ApS Bankrupt
- SIE DANMARK A/S Bankrupt
- SKIBDAN XXX ApS Bankrupt
- Selskabet af 1/10 2020 ApS Bankrupt
- Selskabet af anden januar 2018 ApS Bankrupt
- Stjerne Malermester Service ApS Bankrupt
- TRIVIRIX DENMARK ApS Bankrupt
- Tempoo Service ApS Bankrupt
- Victor Hjorth Holding Ivs Bankrupt
- 2WAYS-IT ApS Opløst
- A.W. FABER-CASTELL NORDIC ApS Active
- ALTOX A/S Active
- CARESTREAM HEALTH DENMARK ApS Opløst
- CarPal ApS Active
- DANTEC DYNAMICS A/S Active
- DJV Holding ApS Active
- Enexi Nordic ApS Active
- Evergreen Garden Care Danmark A/S Active
- FLEXPAY ApS Fusioneret
- GETINGE DANMARK A/S Active
- GSB Clinical Services ApS Active
- GSB Grafisk ApS Active
- HNC Invest ApS Opløst
Similar companies in Ballerup
- SIEMENS HEALTHCARE A/S Ballerup
- PBN MEDICALS DENMARK A/S Ballerup
- PKI Denmark ApS Ballerup
- Nowus Healthcare A/S Ballerup
- CISI Systems A/S Skovlunde
- DANISH HEALTHCARE ApS Ballerup
- ARJO Danmark A/S Ballerup
- REVVITY DANMARK A/S Ballerup
- GETINGE DANMARK A/S Skovlunde
- BIOMÉRIEUX DENMARK ApS Ballerup
- MEDTRONIC A/S Skovlunde
- Acuson Denmark A/S Ballerup
Questions and answers about Aristo Pharma Nordic ApS
Has Aristo Pharma Nordic ApS gone bankrupt?
No, Aristo Pharma Nordic ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Aristo Pharma Nordic ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of Aristo Pharma Nordic ApS?
John Hudson Kriwet is the CEO of Aristo Pharma Nordic ApS.
Who is the auditor of Aristo Pharma Nordic ApS?
Aristo Pharma Nordic ApS most recently used Baker Tilly Denmark.
When was Aristo Pharma Nordic ApS founded?
Aristo Pharma Nordic ApS was founded on 8 February 2011.
What is the equity of Aristo Pharma Nordic ApS?
Equity was DKK 185k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.